Terns Pharmaceuticals, Inc. Contracts & Agreements
53 Contracts & Agreements
- Business Finance (12 contracts)
- Business Operations (2)
- Human Resources (29)
- Intellectual Property (3)
- Real Estate (3)
- Uncategorized (4)
- Separation Agreement between Terns, Inc. and Bryan Yoon dated July 23, 2024 (Filed With SEC on November 12, 2024)
- Transition Agreement between Terns, Inc. and Mark Vignola dated July 23, 2024 (Filed With SEC on November 12, 2024)
- Amendment No. 2 to 2022 Employment Inducement Award Plan (Filed With SEC on November 12, 2024)
- Underwriting Agreement, dated September 10, 2024, between Terns Pharmaceuticals, Inc. and Jefferies LLC and TD Securities (USA) LLC, as representatives of the several underwriters... (Filed With SEC on September 12, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on September 12, 2024)
- Separation Agreement between Terns, Inc. and Erin Quirk dated May 7, 2024 (Filed With SEC on August 5, 2024)
- First Amendment to Office Lease dated July 1, 2024 (Filed With SEC on July 3, 2024)
- Second Amended and Restated Non-Employee Director Compensation Program (Filed With SEC on May 13, 2024)
- Employment Agreement by and between the Registrant and Amy Burroughs dated February 7, 2024 (Filed With SEC on May 13, 2024)
- Description of Securities (Filed With SEC on March 14, 2024)
- Amended and Restated Employment Agreement by and between the Registrant and Erin Quirk, M.D (Filed With SEC on March 14, 2024)
- Amended and Restated Employment Agreement by and between the Registrant and Bryan Yoon, Esq (Filed With SEC on March 14, 2024)
- Employment Agreement by and between the Registrant and Jill M. Quigley (Filed With SEC on March 14, 2024)
- Amended and Restated Employment Agreement by and between the Registrant and Mark Vignola (Filed With SEC on March 14, 2024)
- Separation Agreement between Terns, Inc. and Senthil Sundaram dated August 2, 2023 (Filed With SEC on November 14, 2023)
- Amendment No. 1 to 2022 Employment Inducement Award Plan (Filed With SEC on November 14, 2023)
- Clawback Policy (Filed With SEC on November 14, 2023)
- Sales Agreement, dated May 15, 2023, by and between Terns Pharmaceuticals, Inc. and Cowen and Company, LLC (Filed With SEC on May 15, 2023)
- Underwriting Agreement, dated December 20, 2022, among Terns Pharmaceuticals, Inc. and Jefferies LLC and Cowen and Company, LLC, as representatives of the several underwriters... (Filed With SEC on December 23, 2022)
- 2022 Employment Inducement Award Plan (Filed With SEC on November 9, 2022)
- Form of Stock Option Grant Notice and Stock Option Agreement under the 2022 Employment Inducement Award Plan (Filed With SEC on November 9, 2022)
- Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement under the 2022 Employment Inducement Award Plan (Filed With SEC on November 9, 2022)
- Underwriting Agreement, dated August 11, 2022, between Terns Pharmaceuticals, Inc. and Cowen and Company, LLC, as representative of the several underwriters named therein (Filed With SEC on August 16, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on August 16, 2022)
- Description of Securities (Filed With SEC on March 7, 2022)
- Employment Agreement by and between the Registrant and Erin Quirk, M.D (Filed With SEC on March 7, 2022)
- Employment Agreement by and between the Registrant and Bryan Yoon, Esq (Filed With SEC on March 7, 2022)
- Amended and Restated Non-employee Director Compensation Program (Filed With SEC on March 7, 2022)
- Amended and Restated Non-employee Director Compensation Program (Filed With SEC on November 15, 2021)
- Description of Securities (Filed With SEC on March 30, 2021)
- Form of Underwriting Agreement (Filed With SEC on February 1, 2021)
- Form of Common Stock Certificate (Filed With SEC on February 1, 2021)
- 2021 Incentive Award Plan (Filed With SEC on February 1, 2021)
- Form of Stock Option Grant Notice and Stock Option Agreement under the 2021 Incentive Award Plan (Filed With SEC on February 1, 2021)
- Form of Restricted Stock Award Grant Notice and Restricted Stock Award Agreement under the 2021 Incentive Award Plan (Filed With SEC on February 1, 2021)
- Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement under the 2021 Incentive Award Plan (Filed With SEC on February 1, 2021)
- 2021 Employee Stock Purchase Plan (Filed With SEC on February 1, 2021)
- Employment Agreement by and between the Registrant and Erin Quirk, M.D (Filed With SEC on February 1, 2021)
- Employment Agreement by and between the Registrant and Senthil Sundaram (Filed With SEC on February 1, 2021)
- Employment Agreement by and between the Registrant and Mark Vignola, Ph.D (Filed With SEC on February 1, 2021)
- Non-Employee Director Compensation Program (Filed With SEC on February 1, 2021)
- Form of Indemnification Agreement for directors and officers (Filed With SEC on February 1, 2021)
- Amended and Restated Investors Rights Agreement, dated December 29, 2020, by and among the Registrant and the investors listed therein (Filed With SEC on January 15, 2021)
- Lease, dated March 1, 2019, by and between the Registrant and DWF IV Century Plaza, LLC (Filed With SEC on January 15, 2021)
- Lease, dated June 15, 2018, by and between the Registrant and Changning Raffles Shanghai (Filed With SEC on January 15, 2021)
- 2017 Equity Incentive Plan, as amended (Filed With SEC on January 15, 2021)
- Form of Stock Option Grant Notice and Stock Option Agreement under 2017 Equity Incentive Plan, as amended (Filed With SEC on January 15, 2021)
- Form of Early Exercise Stock Option Grant Notice and Stock Option Agreement under 2017 Equity Incentive Plan, as amended (Filed With SEC on January 15, 2021)
- Form of International Stock Option Grant Notice and Stock Option Agreement under 2017 Equity Incentive Plan, as amended (Filed With SEC on January 15, 2021)
- Exclusive License Agreement, dated as of February 9, 2018, between Terns Pharmaceuticals, Inc. and Eli Lilly and Company (Filed With SEC on January 15, 2021)
- Exclusive License Agreement, dated as of March 9, 2018, between Terns Pharmaceuticals, Inc. and Eli Lilly and Company (Filed With SEC on January 15, 2021)
- Assignment Agreement, dated as of June 24, 2019, by and among Terns Pharmaceuticals, Inc. and Vintagence Biotechnology Ltd (Filed With SEC on January 15, 2021)
- Exclusive Option and License, dated as of July 27, 2020, by and among Terns Pharmaceuticals, Inc., Terns, Inc., CaspianTern LLC, Hansoh (Shanghai) Healthtech Co., Ltd. and Jiangsu... (Filed With SEC on January 15, 2021)
